Astel­las joins Pfiz­er in emerg­ing North Car­oli­na hub, un­veil­ing new $100M gene ther­a­py man­u­fac­tur­ing site

The small city of San­ford, NC, was once known for its brick pro­duc­tion, but now is quick­ly be­com­ing a hub in the biotech world. And now Astel­las is the lat­est to pitch its tent in the area.

The com­pa­ny’s gene ther­a­py branch, which came out of the ac­qui­si­tion of Au­dentes in 2019, has opened a new man­u­fac­tur­ing fa­cil­i­ty in the city, com­pris­ing 135,000 square feet and shelling out $100 mil­lion. Astel­las de­signed the site to pro­vide clin­i­cal and com­mer­cial-scale man­u­fac­tur­ing ca­pa­bil­i­ties for its pipeline of AAV vec­tors for gene ther­a­pies, which in­cludes pro­grams from both Astel­las and Au­dentes’ port­fo­lios.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER